FdaApplication

NDA 213006

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSUMITOMO PHARMA AMERICA INC
application_typeNDA
approval_date2020-12-23

Products (1)

ProductActive ingredientStrengthDosage form
GEMTESAVIBEGRON75MGTABLET;ORAL

1 product